The drug development landscape in Parkinson's
This event will be held in person. Please note slightly the later start time of 12:15pm
Originally a biochemist, Dr Kevin McFarthing’s career included R&D leadership positions in life sciences research products with Amersham, diagnostics with Serono and consumer healthcare with Reckitt Benckiser. He curates the Parkinson’s Hope List (bit.ly/ParkinsonsHopeList), a database of potential therapies in research and clinical stages. Kevin was diagnosed with Parkinson’s in 2012 at the age of 55.
24 May 2022, 12:15 (Tuesday, 5th week, Trinity 2022)
Dorothy Crowfoot Hodgkin Building, off South Parks Road OX1 3QU
This seminar will be held in the Dorothy Crowfoot Hodgkin Building (Phase II Biochemistry), Ground Floor Seminar Room (20-140). Email: email@example.com for more details.
Dr Kevin McFarthing (Research Advisor, Parkinson’s UK Oxford Branch)
Department of Physiology, Anatomy and Genetics (DPAG)
Lorraine Dyson (University of Oxford)
Organiser contact email address:
Professor Richard Wade-Martins (Professor of Molecular Neuroscience, University of Oxford)
OPDC Seminar Series (DPAG)
Members of the University only